This case comes before the court on a motion in forma pauperis by William A. Sorenson, a federal prisoner, to vacate a judgment of conviction and sentence pursuant to the provisions of 28 U.S.C. § 2255, and presents serious constitutional questions.
Petitioner was convicted by a jury in the United States District Court for the Eastern District of New York on March 21, 1962, for violation of 21 U.S.C. § 174, and was sentenced to imprisonment for a term of ten years, to begin upon completion of a ten to thirty year term in a New York State prison for a conviction of manslaughter in the first degree. The indictment alleged: “That on or about June 7, 1959, at 628 78th Street, Brooklyn, New York, within the Eastern District of New York, the defendant WILLIAM A. SORENSON did knowingly and unlawfully receive and conceal a narcotic drug, to wit: approximately 2 kilograms, 924 grams and 208 milligrams of Isoriipecaine, knowing the same to have been imported contrary to law. (Title 21 United States Code § 174)”. The relevant portion of Section 174 charges that anyone who receives, conceals, or facilitates the concealment or sale of a narcotic drug which has been imported into the United States contrary to law “knowing the same to have been imported or brought into the United States contrary to law * * * shall be imprisoned not less than five or more than twenty years * * The section further provides that: “Whenever on trial for a violation of this section the defendant is shown to have or to have had possession of the narcotic drug, such possession shall be deemed sufficient evidence to authorize conviction unless the defendant explains the possession to the satisfaction of the jury.”
At the trial the Government introduced no evidence of either illegal importation or Sorenson’s knowledge of illegal importation. Instead of proof of these elements of the offense, the Government chose to rely entirely upon the statutory presumptions arising under the above section from proof of possession alone. On appeal Sorenson challenged the constitutionality of these presumptions but the Court of Appeals upheld their validity (
Preliminarily it is necessary to inquire whether in the present posture of the case § 2255 is available for a collateral attack upon the constitutionality of the § 174 presumption as it applies to isonipecaine (popularly known and hereafter referred to as “demerol”). Townsend v. Sain,
Thus the court is faced with the task of applying the Leary standards to the presumptions created by § 174 insofar as they apply to demerol. The statute creates two presumptions arising from possession of demerol, (i) concealment or receipt of demerol illegally imported, and (ii) knowledge that demerol was illegally imported. For the resolution of this issue it is necessary for the court to address itself only to the latter presumption. The test for determining the validity of a statutory presumption was first enunciated in Tot v. United States,
At the outset it should be noted that hard-core narcotics such as opium or heroin which have never been produced in the United States are not here involved (Trotter v. United States,
At the time the statute was amended to extend the definition of a narcotic drug to include demerol, Congress was anxious to check the pernicious effect resulting from its indiscriminate use. In fact, the House Committee Report (H.R.Rep. No. 1588, 78th Cong., 2d Sess. (1944), also adopted as the Senate Report (S.Rep. No. 1004, 78th Cong,. 2d Sess. (1944)) stated that this newly discovered synthetic drug produced
There remains the question whether the Leary standards invalidating the § 174 presumption as applied to demerol should be applied retroactively to 1959 —a question which might wait for a higher court determination were it not for the fact that the liberty and constitutional rights of the petitioner are presently at stake. In approaching a resolution of the issue the Supreme Court has enumerated the following criteria: (a) the purpose to be served by the new standards; (b) the extent of the reliance by law enforcement authorities on the old standards, and (c) the effect on the administration of justice of a retroactive application of the new standards. Stovall v. Denno,
Summarizing the cases, it appears that where the primary purpose of a new rule is prophylactic in nature such as the prevention of potential improper police activity, the damage is already done and cannot be undone by overturning existing convictions. In such cases the rule is not applied retroactively; see, e. g., Linkletter v. Walker,
With these principles in mind, the court weighs the issue of retroactivity. Since the available evidence does not support the rationality of the knowledge part of the § 174 presumption to the extent that it applies to demerol, it becomes increasingly evident that there is no integrity to the fact finding process as to an essential element of this offense. The primary purpose of the Leary rule is to protect the innocent from conviction because of the unreliability of irrational presumptions as to a material element of a crime. In this case the presumption is so untrustworthy that it falls within the categories discussed in Johnson v. New Jersey, supra, justifying retroactive application. In spite of countervailing considerations such as the probable reliance in the past of federal prosecutors upon the § 174 presumption and the probable incarceration of a number of federal prisoners for possession of demerol, the court must apply Leary principles retroactively under the criteria of Roberts v. Russell, supra, where the Supreme Court said that “even if the impact of retroactivity may be significant, the constitutional error presents a serious risk that the issue of guilt or innocence may not have been reliably determined.”
The conclusion follows that the petitioner has been deprived of his constitutional right to due process and the court accordingly grants petitioner’s motion to
Notes
.The immediate concern of Congress was to bring distribution of the drug under governmental supervision. As stated in the House Report (p. 2) “unless subjected to the same enforcement control as morphine, the manufacture, distribution and use of the new synthetic drug will soon be productive of serious abuses with the inevitable spread of drug addiction.” This alarm was expressed to the House by the bill’s major supporter, Representative Doughton, who stated that “unless this drug is placed under control there is no telling what the consequences may be.” 90 Cong.Rec. 5389 (1944).
. Act of July 1, 1944, ch. 377, § 8, 58 Stat. 721.
. “Isonipecaine” [demerol] is defined in 26 U.S.C. § 4731 as follows: “The word ‘isonipecaine’, as used in this part shall mean any substance identified chemically as l-methyl-4-phenyl-piperidine-4-car-boxylic acid ethyl ester, or any salt thereof, by whatever trade name designated.”
